| P50 | author | Naoto Adachi | Q100766030 |
| | Reiji Yoshimura | Q107749594 |
| P2093 | author name string | Atsuo Nakagawa | |
| | Toshiaki Kikuchi | |
| | Masaki Kato | |
| | Takashi Tsuboi | |
| | Yoichiro Watanabe | |
| | Koichiro Watanabe | |
| | Norio Yasui-Furukori | |
| | Seiji Hongo | |
| | Kazuhira Miki | |
| | Hitoshi Ueda | |
| | Takaharu Azekawa | |
| | Eiichi Katsumoto | |
| | Eiichiro Goto | |
| | Kouji Edagawa | |
| | Yukihisa Kubota | |
| P2860 | cites work | Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) | Q21999020 |
| | Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review | Q26751363 |
| | Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data | Q30878126 |
| | Consultant psychiatrists' experiences of and attitudes towards shared decision making in antipsychotic prescribing, a qualitative study | Q33562302 |
| | National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 |
| | Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. | Q34098311 |
| | Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence | Q34597937 |
| | Interventions for Sleep Disturbance in Bipolar Disorder | Q35140930 |
| | Determinants of adherence to treatment in bipolar disorder: a comprehensive review | Q38089269 |
| | Polypharmacy and bipolar disorder: what's personality got to do with it? | Q38143335 |
| | Is there consensus across international evidence-based guidelines for the management of bipolar disorder? | Q39161964 |
| | Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder | Q42869342 |
| | Psychopharmacology: rational and irrational polypharmacy | Q43463430 |
| | Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011. | Q44978259 |
| | Polypharmacy in Maintenance of Bipolar Disorder. | Q50537177 |
| | Factors in choosing atypical antipsychotics: toward understanding the bases of physicians' prescribing decisions. | Q51926147 |
| | Mechanisms Underpinning the Polypharmacy Effects of Medications in Psychiatry. | Q55425591 |
| | Psychotropic polypharmacy for the treatment of bipolar disorder in Taiwan | Q87022001 |
| | Vulnerability to bipolar disorder is linked to sleep and sleepiness | Q91235621 |
| | Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI) | Q91839634 |
| | Changes in prescribing for bipolar disorder between 2009 and 2016: national-level data linkage study in Scotland | Q92000984 |
| | Clinical features related to rapid cycling and one-year euthymia in bipolar disorder patients: A multicenter treatment survey for bipolar disorder in psychiatric clinics (MUSUBI) | Q100457942 |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | e2764 | |
| P577 | publication date | 2020-10-22 | |
| P1433 | published in | Human Psychopharmacology | Q15751477 |
| P1476 | title | Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI study | |